O-091 A randomized phase II trial of docetaxel alone and in combinationwith gefitinib (IRESSA) as second-line therapy for patients with non-small-cell lung cancer
Robinet, G., Falchero, L., Perol, M., Thomas, P., Monnet, I., Grivaux, M., Crequit, J., Letreut, J., Paillotin, D., Chouaid, C.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80225-9
Date:
July, 2005
File:
PDF, 140 KB
english, 2005